Literature DB >> 27825692

Barriers to Accessing Optimal Esophageal Cancer Care for Socioeconomically Disadvantaged Patients.

Christina M Lineback1, Colin M Mervak1, Sha'shonda L Revels2, Micheal T Kemp1, Rishindra M Reddy3.   

Abstract

BACKGROUND: The 5-year survival of patients with low socioeconomic status (SES) and esophageal cancer is significantly lower than that in patients with high SES. It is poorly understood what causes these worse outcomes. We hypothesized that a qualitative approach could elucidate the underlying causes of these differences.
METHODS: Patients with a diagnosis of esophageal cancer were recruited through flyers in regional cancer centers as well as through Facebook advertisements in cancer support groups and newspapers; they participated in a 1-hour semistructured interview or completed an online survey. Patients were stratified into low- and high-SES groups and were surveyed about their health history and access to cancer care. Data were coded into common themes based on participant responses.
RESULTS: Eighty patients completed the interviews or surveys, with 38 in the high-SES group and 42 in the low-SES group. There were no clinically significant differences between the groups in comorbidities and cancer staging. Patients with low SES were offered operative treatment at significantly lower rates (19 of 42 [44.7%] versus 29 of 38 [76.3%]; p = 0.0048), had a decreased rate of second opinions (10 of 42 [23.8%] versus 25 of 38 [65.8%]; p = 0.00016), and were more likely to lose their jobs (14 of 42 [33.3%] versus 1 of 38 [2.6%]; p = 0.00044) than their high-SES counterparts. Thematic analysis found that communication difficulties, lack of understanding of treatment, and financial troubles were consistently reported more prominently in the lower-SES groups. Having a facilitator (eg, social worker) improved care by helping patients navigate complex treatments and financial concerns.
CONCLUSIONS: Financial and communication barriers exist, which may lead to disparities in cancer outcomes for patients with low SES. There is a critical need for medical advocates to assist patients with limited resources.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27825692     DOI: 10.1016/j.athoracsur.2016.08.085

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma.

Authors:  Vignesh Raman; Oliver K Jawitz; Soraya L Voigt; Kristen E Rhodin; Anthony W Kim; Betty C Tong; Thomas A D'Amico; David H Harpole
Journal:  Ann Thorac Surg       Date:  2020-07-03       Impact factor: 4.330

2.  Disparities in esophageal cancer: less treatment, less surgical resection, and poorer survival in disadvantaged patients.

Authors:  Francisco Schlottmann; Charles Gaber; Paula D Strassle; Fernando A M Herbella; Daniela Molena; Marco G Patti
Journal:  Dis Esophagus       Date:  2020-03-05       Impact factor: 3.429

3.  Influence of Patients' Age in the Utilization of Esophagectomy for Esophageal Adenocarcinoma.

Authors:  Francisco Schlottmann; Paula D Strassle; Daniela Molena; Marco G Patti
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2018-10-25       Impact factor: 1.878

4.  Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review.

Authors:  Ernesto Sosa; Gail D'Souza; Aamna Akhtar; Melissa Sur; Kyra Love; Jeanette Duffels; Dan J Raz; Jae Y Kim; Virginia Sun; Loretta Erhunmwunsee
Journal:  CA Cancer J Clin       Date:  2021-05-20       Impact factor: 286.130

5.  Socioeconomic differences in experiences with treatment of coronary heart disease: a qualitative study from the perspective of elderly patients.

Authors:  Sara Lena Schröder; Astrid Fink; Matthias Richter
Journal:  BMJ Open       Date:  2018-11-13       Impact factor: 2.692

6.  Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer.

Authors:  Lauren Midthun; Sungjin Kim; Andrew Hendifar; Arsen Osipov; Samuel J Klempner; Joseph Chao; May Cho; Michelle Guan; Veronica R Placencio-Hickok; Alexandra Gangi; Miguel Burch; De-Chen Lin; Kevin Waters; Katelyn Atkins; Mitchell Kamrava; Jun Gong
Journal:  World J Gastrointest Oncol       Date:  2022-02-15

7.  Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.

Authors:  Hla-Hla Thein; Kika Anyiwe; Nathaniel Jembere; Brian Yu; Prithwish De; Craig C Earle
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

Review 8.  A narrative review of socioeconomic disparities in the treatment of esophageal cancer.

Authors:  Aaron M Delman; Allison M Ammann; Kevin M Turner; Dennis M Vaysburg; Robert M Van Haren
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

9.  Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?

Authors:  Cary Jo R Schlick; Rhami Khorfan; David D Odell; Ryan P Merkow; David J Bentrem
Journal:  Ann Surg Oncol       Date:  2020-06-09       Impact factor: 4.339

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.